SCHEMBL371437

SCHEMBL371437

CCCCCCCCCCCCCCCC(=O)ONCC(=O)OC1CC(=O)NC1=O

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.41
PRKCA P17252 6/20 0.39
NAAA Q02083 5/20 0.38
DGKA P23743 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL180318 0.87 PRKCA (0.49) PRKCANAAADGKA
SCHEMBL3628006 0.87 PRKCA (0.49) PRKCANAAADGKA
SCHEMBL2099423 0.86 PRKCA (0.47) PRKCANAAADGKA
SCHEMBL20589363 0.80 PRKCA (0.38) PRKCANAAA
SCHEMBL1517935 0.79 PRKCA (0.41) PRKCANAAADGKA
SCHEMBL6551912 0.76 HSD17B10 (0.39) PRKCA
SCHEMBL6381422 0.75 MMP2 (0.41) PRKCA
SCHEMBL9204462 0.75 NAAA (0.41) NAAA
SCHEMBL10727648 0.74 ADRA1A (0.42) PRKCA
SCHEMBL10877677 0.73 GPR84 (0.43) PRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2410031-B1 BASE MATERIAL FOR SPRAYING COMPRISING LOW-MOLECULAR GELLING AGENT NISSAN CHEMICAL CORP (JP) 2019-04-24 EP disclosed
EP-2664321-B1 Medical instrument and preparation comprising a lipid peptide and gum arabic NISSAN CHEMICAL IND LTD (JP) 2018-08-22 EP disclosed
EP-2494953-B1 COMPOSITION FOR USE AS COSMETIC OR EXTERNAL SKIN PREPARATION NISSAN CHEMICAL IND LTD (JP) 2017-09-27 EP disclosed
US-9561255-B2 Cosmetic, external skin preparation, and medical instrument NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-02-07 US disclosed
EP-2319894-B1 NOVEL LIPID DIPEPTIDE AND GEL NISSAN CHEMICAL IND LTD (JP) 2016-10-26 EP disclosed
US-9333158-B2 Spray base material including low-molecular gelator NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-05-10 US disclosed
US-9289496-B2 Lipid dipeptide and gel NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-03-22 US disclosed
US-9265833-B2 Lipid dipeptide and gel NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-02-23 US disclosed
US-8999300-B2 Cosmetic, external skin preparation, and medical instrument NISSAN CHEMICAL INDUSTRIES LTD. (JP) 2015-04-07 US disclosed
EP-2664321-A2 Medical instrument Nissan Chemical Industries, Ltd. (JP) 2013-11-20 EP disclosed
US-20130267610-A1 NOVEL LIPID DIPEPTIDE AND GEL NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-10-10 US disclosed
US-20130267609-A1 NOVEL LIPID DIPEPTIDE AND GEL NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-10-10 US disclosed
US-20130084305-A1 COSMETIC, EXTERNAL SKIN PREPARATION, AND MEDICAL INSTRUMENT KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2013-04-04 US disclosed
US-20120258059-A1 COSMETIC, EXTERNAL SKIN PREPARATION, AND MEDICAL INSTRUMENT NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-10-11 US disclosed
EP-2494953-A1 COSMETIC AND EXTERNAL SKIN PREPARATION, AND MEDICAL INSTRUMENT Nissan Chemical Industries, Ltd. (JP) 2012-09-05 EP disclosed
US-20120035108-A1 SPRAY BASE MATERIAL INCLUDING LOW-MOLECULAR GELATOR KYUSHU UNIVERSITY (JP) 2012-02-09 US disclosed
EP-2410031-A1 BASE MATERIAL FOR SPRAYING COMPRISING LOW-MOLECULAR GELLING AGENT Nissan Chemical Industries, Ltd. (JP) 2012-01-25 EP disclosed
US-20110183913-A1 NOVEL LIPID DIPEPTIDE AND GEL NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-07-28 US disclosed
EP-2319894-A1 NOVEL LIPID DIPEPTIDE AND GEL Nissan Chemical Industries, Ltd. (JP) 2011-05-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130084305-A1 COSMETIC, EXTERNAL SKIN PREPARATION, AND MEDICAL INSTRUMENT CUTA, F12, SGMS1 CNR2 3299/4885PRKCA 1391/4885NAAA 1329/4885
US-20130267609-A1 NOVEL LIPID DIPEPTIDE AND GEL NGLY1, GGH, ARGLU1 CNR2 1762/4885PRKCA 3957/4885NAAA 368/4885
US-20110183913-A1 NOVEL LIPID DIPEPTIDE AND GEL NGLY1, ARGLU1, GGH CNR2 1736/4885PRKCA 4051/4885NAAA 332/4885
US-20120258059-A1 COSMETIC, EXTERNAL SKIN PREPARATION, AND MEDICAL INSTRUMENT CUTA, F12, SGMS1 CNR2 3299/4885PRKCA 1391/4885NAAA 1329/4885
US-20130267610-A1 NOVEL LIPID DIPEPTIDE AND GEL NGLY1, GGH, ARGLU1 CNR2 1762/4885PRKCA 3957/4885NAAA 368/4885
US-20120035108-A1 SPRAY BASE MATERIAL INCLUDING LOW-MOLECULAR GELATOR CUTA, DSG1, STMN1 CNR2 874/4885PRKCA 2707/4885NAAA 1845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.